Takanashi; Yosuke

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takanashi; Yosuke.The latest application filed is for "water soluble adjuvant and composition containing same".

Company Profile

3.7.20

Takanashi; Yosuke - Osaka-shi Osaka
Takanashi; Yosuke - Konohana-ku Osaka-shi
TAKANASHI; Yosuke - Osaka JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Water Soluble Adjuvant And Composition Containing Same App 20220241409 - Ban; Hitoshi ; et al.	2022-08-04
Water Soluble Adjuvant And Composition Containing Same App 20220211844 - Ban; Hitoshi ; et al.	2022-07-07
Wt1 Cancer Antigen Peptides And Peptide Conjugates Comprising The Peptides App 20210100886 - BAN; Hitoshi ; et al.	2021-04-08
Conjugate Of Wt1-derived Peptides And Composition Comprising The Same App 20200368338 - BAN; Hitoshi ; et al.	2020-11-26
Antibody-Drug Conjugates Including Hemiasterlin Derivative App 20200247847 - Kind Code	2020-08-06
Chemically Activated Water-soluble Prodrug App 20200207782 - KAMIOKA; Seiji ; et al.	2020-07-02
Conjugate Vaccine Using Trimming Function Of Erap1 App 20200171136 - BAN; Hitoshi ; et al.	2020-06-04
Conjugate vaccine using trimming function of ERAP1 Grant 10,588,952 - Ban , et al.	2020-03-17
Wt1 Helper Peptides And Combinations Of Wt1 Helper Peptide And Conjugate Of Cancer Antigen Peptides App 20200016255 - BAN; Hitoshi ; et al.	2020-01-16
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of App 20190241569 - Li; Chiang Jia ; et al.	2019-08-08
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20190241550 - Tsuboi; Katsunori ; et al.	2019-08-08
Bicyclic heterocyclic amide derivative Grant 10,294,237 - Ban , et al.	2019-05-21
Wt1 Antigen Peptide Conjugate Vaccine App 20190030149 - LI; Chiang Jia ; et al.	2019-01-31
Bicyclic Heterocyclic Amide Derivative App 20180194773 - Ban; Hitoshi ; et al.	2018-07-12
Wt1 Antigen Peptide Conjugate Vaccine App 20160114019 - Li; Chiang Jia ; et al.	2016-04-28
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20160075697 - Tsuboi; Katsunori ; et al.	2016-03-17
Conjugate Vaccine Using Trimming Function Of Erap1 App 20160045582 - BAN; Hitoshi ; et al.	2016-02-18
3-(aryl Or Heteroaryl) Methyleneindolin-2-one Derivatives As Inhibitors Of Cancer Stem Cell Pathway Kinases For The Treatment Of Cancer App 20160031888 - Li; Chiang Jia ; et al.	2016-02-04
WT1 antigen peptide conjugate vaccine Grant 9,248,173 - Li , et al. February 2, 2	2016-02-02
Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative Grant 9,227,962 - Tsuboi , et al. January 5, 2	2016-01-05
WT1 antigen peptide conjugate vaccine Grant 9,181,302 - Li , et al. November 10, 2	2015-11-10
Wt1 Antigen Peptide Conjugate Vaccine App 20150238587 - LI; Chiang Jia ; et al.	2015-08-27
Uracil derivative and use thereof for medical purposes Grant 9,040,516 - Shiro , et al. May 26, 2	2015-05-26
Heterocyclic Substituted-3-heteroarylidenyl-2-indolinone Derivative App 20140275076 - Tsuboi; Katsunori ; et al.	2014-09-18
Uracil Derivative And Use Thereof For Medical Purposes App 20140179670 - Shiro; Tomoya ; et al.	2014-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.